false
OasisLMS
Catalog
SCCM Resource Library
Year in Review Internal Medicine: Topic 1
Year in Review Internal Medicine: Topic 1
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Lokesh Dayal, a medical intensivist, discussed two landmark studies on community-acquired pneumonia (CAP). The first, CAPE-COD, explored the benefits of hydrocortisone in severe CAP, showing reduced 28-day mortality without significant risks of infection or GI bleeds, although requiring more insulin use. The second study, ACORN, compared cefepime and piperacillin-tazobactam for pseudomonal coverage, finding no significant differences in kidney outcomes, although cefepime was linked to higher delirium. These studies provide insights on treatment practices for severe CAP, particularly regarding corticosteroid use and antibiotic choice.
Asset Caption
Year in Review | Year in Review: Internal Medicine
Meta Tag
Content Type
Presentation
Membership Level
Professional
Membership Level
Select
Year
2024
Keywords
community-acquired pneumonia
hydrocortisone
antibiotic choice
CAPE-COD study
ACORN study
×
Please select your language
1
English